Diabetes Health in The News Podcast: Liraglutide Aids Long-Term Weight Loss of Diabetes Patients

Click here to listen to the audio recording of Diabetes Health in The News.

Clinical trials have recently studied how a daily dose of 3 milligrams of Liraglutide,  (Novo Nordisk’s,  Saxenda)  affected weight loss in diabetes patients. The study involved 846 obese or overweight patients, living with type 2 diabetes. After  56 weeks, the participants who were prescribed a 3-milligram dose, lost about 14 pounds. This group also experienced a significant reduction in BMI and waist circumference,  in comparison to participants receiving a placebo and lower dose of Liraglutide .

These findings suggest that prescribing a 3. milligram daily dose of the medication can not only help to control glucose levels, but it can also help to promote long-term weight loss.

These findings were published in the Journal of the American Medical Association on August 18th, 2015 .

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.